Dsuvia Gets Warning Letter As US FDA’s Opioid Decisions Complicate Commissioner Race

 
• By Sarah Karlin-Smith
  
The Dsuvia warning letter drew a lot of attention from FDA officials.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership